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• Less deformable 
• More fragile 
• More rigid 
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STROKE  1 
• Abrupt onset of neurological deficit 
• Mostly ischemic 
• Affects large and medium vessels 
• High risk (fatal in 1/10 patients) 
• Clinical features 
• Hemiparesis or focal seizures 
• Weakness, spasticity, epilepsy 
• Cognitive impairment 
• Compromised IQ 
•  language, social and personal 
skills 
• High recurrence risk 
• 2-3 yrs. after first stroke 
CEREBRAL VASCULOPATHY 
SILENT CEREBRAL INFARCTION (SCI)  
• Not clinically apparent 
• No neurological anomalies or not 
related to the MRI abnormalities  
• 25% SCA children  6 years old 
• 39% SCA children 18 years old 
• Affects small vessels  
• Rarely fatal 
• High recurrence risk 
2 
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• Transcranial Doppler ultrasonography (TCD) 
• Cerebral Magnetic Resonance Imaging (MRI) 
• Computer Tomography (CT) 
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SCREENING & DIAGNOSIS 
MRI  
TCD 
Measures time-averaged mean of 
maximum velocity (TAMMV) of 
blood flow in the middle cerebral 
artery 
Sources (images): WikiCommons Licenses   
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STROKE RISK CLASSIFICATION IN SCA  
High Risk – TAMMV ≥ 200 cm/s 
Conditional – 170 cm/s < TAMMV < 199 cm/s 
“Normal” – TAMMV < 170 cm/s 
TAMMV  
Adapted from: WikiCommons License  
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THERAPEUTIC STRATEGIES  
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Specific/sensitive Biomarkers of Cerebral Vasculopathy Risk 
Regular blood transfusion therapy 
Hydroxyurea 
Bone Marrow or Human Stem Cell Transplant 
Cerebral Revascularization Surgery 
Genome Editing… 
Alloimunization 
Iron overload 
January 10th 2018 Seminários DGH - INSA  
RISK FACTORS  
• Hypertension 
• Diabetes 
• Hyperlipidemia 
• Atrial fibrillation 
• Renal disease 
CNS vasculopathy 
(intra- or extracranial) 
• Stenosis 
• Occlusion 
• Dissection 
• Moyamoya 
 Hb O2 saturation,  O2 demand 
• Acute chest syndrome 
• Low baseline O2 saturation 
• Fever ( O2 demand) 
• Seizure ( O2 demand) 
 Cerebral Blood Flow 
 Cerebrovascular reserve 
• Low baseline Hb 
• High %HbS (especially >40%) 
Anemia 
(relative and acute) 
• Low baseline Hb 
• Relative acute drop in 
Hb (<5.5 g/dL)  
• Parvovirus B19 
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PUTATIVE GENETIC MODULATORS OF PEDIATRIC STROKE IN SCA 
10 Janeiro 2018 Seminários DGH Marisa Silva 
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STRING v.10.5 
VCAM-1 
• Vascular adhesion molecule 1 
• Syaloglycoprotein (immunoglobullin family)  
• Gene location: chr. 1 (q31-q32) 
• 25 kb 
• 9 exons 
• Homodimeric protein 
• 739 aa 
• Cell adhesion 
• Heterotypic cell-cell adhesion via plasma membrane cell 
adhesion molecules 
• Cell adhesion molecule binding 
• Response to hypoxia 
• Acute inflammatory response 
• Chronic inflammatory response 
• Integrin binding 
• Leukocyte cell-cell adhesion 
• Cellular response to tumor necrosis factor 
• Interferon-gamma-mediated signalling pathway 
• Cell-matrix adhesion 
• Leukocyte tethering or rolling 
• Leukocyte migration 
• Cellular response to vascular endothelial growth factor stimulus 
    
   Gene Ontology (GO) 
MMDB ID: 4624 
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ITGA4 
• Cell-matrix adhesion involved in ameboidal cell migration 
• Fibronectin binding 
• Focal adhesion 
• Leukocyte cell-cell adhesion 
• Cell-matrix adhesion 
• Integrin mediated signalling pathway 
• Heterotypic cell-cell adhesion 
• Positive regulation of leukocyte tethering or rolling 
• Leukocyte migration 
• Cell adhesion molecule binding 
• Cellular response to cytokine stimulus 
• Substrate adhesion-dependent cell spreading 
    
   Gene Ontology (GO) 
STRING v.10.5 
• Integrin 4; very-late antigen 4 (VLA-4); 
integrin α4β1; CD49D 
• Integrin alpha chain family  
• Gene location: chr. 2 (q31.3) 
• 28 exons 
• Heterodimeric protein 
• 1032 aa 
PDBJ: 3V4V 
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KEGG 
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ENOS 
• Endothelial nitric oxide synthase (constitutive) 
• Gene location: chr. 7 (q35) 
• 21 kb, 26 exons 
• Homodimeric protein (1203 a.a.; 133,289 Da) 
• Co-factors: 
• 5,6,7,8-tetrahydrobiopterin (BH4) 
• Flavin mononucleotide (FMN) 
• Flavin adenine nucleotide (FAD) 
• HEME 
• Stimulated by Calcium/Calmodulin 
• Inhibited by NOSIP and NOSTRIN 
• Nitric oxide synthase activity 
• Arginine binding 
• Heme binding 
• Blood vessel remodeling 
• Cell redox homeostasis 
• Endothelial cell migration 
• Nitric oxide biosynthetic process 
• Positive regulation of blood vessel diameter 
• Regulation of blood pressure 
• Regulation of blood vessel size 
• Removal of superoxide radicals 
• Response of fluid shear stress 
• Vasodilation 
    
   Gene Ontology (GO) STRING v.10.5 
RCSB-PDB: 3NOS 
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POTENTIAL GENETIC MODULATION IN SCA 
• produces nitric oxide (NO) in endotelial cells (bio-availability of NO) 
• vasodilation (resting tonus) (arterial blood pressure regulation)  
• Involved in platelet activation    hypercoagulation (vaso-occlusion) 
eNOS 
• Expressed on the surface of leukocytes, stress 
reticulocytes and SSRBCs 
• Surface cell ligand to VCAM-1 
• Cell-endothelium and cell-cell adhesion (cell adhesion) 
ITGA4 
• Highly expressed on the surface of 
endothelial cells of blood vessels, following 
cytokine stimulation (inflammatory response) 
• Sickle cells are prone to adhere to VCAM-1 
VCAM-1 
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 70 pediatric SCA patients (age ≥ 3 years) 
 Cerebral vasculopathy - 3 main groups: 
 Stroke: ≥ 1 stroke event (n=14) 
 Risk: abnormal TCD and or MRI scan results (n=42) 
Normal: no history of abnormalities in TCD or MRI scans (n=14) 
 Database with clinical, imaging and laboratory data 
POPULATION SAMPLE 
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 PCR, PCR–RFLP 
 Sanger sequencing 
 Next-generation sequencing (NGS) 
• LR-PCR (FailSafe – Epicentre) 
• Nextera XT® (Illumina) 
• MiSeq® (Illumina) 
METHODOLOGY 
VCAM1 
NOS3 
ITGA4 
 Bioinformatic analyses 
• MiSeq® Reporter; BW; GATK; FastQC; 
• IGV; VEP; 
 Statistical analysis 
• SPSS v.24 ( 2 and Fisher tests; FDR correction) 
 In silico analyses 
• Haploview v.4.2 
• MatInspector; TFbind; 
• Human Splicing Finder v.3.0 
• Polyphen2 
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VCAM1 
 7 variants 
 6 SNPs; 1 deletion 
 7 haplotypes (6 promoter variants) 
ITGA4 
 40 variants 
 4 novel 
 34 SNPs; 1 insertion; 5 deletions 
 2 haplotypes 
 32 validated 
NOS3 
 3 variants 
 2 SNPs; 1 VNTR 
 6 haplotypes 
NGS OF ITGA4 REGULATORY REGIONS 
ITGA4 (NGS) 
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ITGA4 VARIANTS (NGS) 
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STATISTICAL ASSOCIATION  
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POTENTIAL MODULATION OF PEDIATRIC STROKE IN SCA 
VCAM1 variant 
• Altered TF binding site (position -1592; RXRF→PRDF) 
• Increased VCAM1 inducible expression 
ENDOTHELIAL DYSFUNCTION 
ITGA4 variants 
• Altered enhancers/silencers  expression 
• Altered cell adhesion to activated 
endothelium 
CELL – ENDOTHELIAL ADHESION 
VASCULOPATHY 
NOS3 variants 
• Decreased NO bio-availability 
• Decreased vascular tone 
VASOCONSTRICTION 
VASO-OCCLUSION 
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FUTURE PROSPECTS 
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e.g.: Gene Panel (NGS) 
In vitro functional studies 
VCAM1, ITGA4, NOS3 – potential therapeutic targets 
Biomarker panel (diagnosis/prognosis) 
Marisa Silva 
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